Other
Emergencies
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Emergencies is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Completed3 · 43%
Recruiting3 · 43%
Withdrawn1 · 14%
Clinical Trials
Trial Activity
7 trials
Sub-Cutaneous Insulin in Hyperglycaemic Emergencies
Withdrawn·—·N/A·NCT00467246
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)